1. Are any rHEALTH® products available for purchase?

Yes, our FVIII test kit is available for sale in English-speaking European countries. Our rHEALTH ONE device is sold to select partners.  Please contact us at bd@rhealth.com for more information. 

2. When will rHEALTH® products be commercially available?

Our rHEALTH point-of-care device is in development and we can notify you once it is commercially available. If you are interested in partnering, please contact us. 

3. Can we distribute your product?

The rHEALTH® products require regulatory approval prior to sales.  We are forming collaborations and partnerships that encompass more than solely distribution at present.

4. What tests can the rHEALTH® perform?

We have demonstrated the technology on over 20 tests.  These include hematology, chemistry, small molecule, biomarker proteins, large proteins, and vital signs.  For a full analyte list, please contact us at bd@rhealth.com.

5. Has the technology been peer-reviewed?

Yes.  The technology has been the subject of peer-reviewed grants and contracts from NASA and NIH's NHLBI.  Furthermore, it has been presented in a variety of talks, abstracts, posters, and publications.  In addition, various external collaborators have demonstrated good performance of the technology in their hands.  Please see our Patents & Publications list or contact us for more information.